Highlights

  • Wide Open Agriculture (ASX:WOA) is shifting its lupin ingredients production strategy toward third-party contract manufacturing.
  • A 6 October 2026 engineering study assessed a proposed industrial-scale lupin protein facility in Western Australia.
  • The company reported an FY26 after-tax loss of AUD 3.64mn, compared with AUD 6.89mn in FY25.
  • Non-binding framework arrangements with prospective manufacturing partners remain subject to further evaluation.

Wide Open Agriculture (ASX:WOA) develops plant-derived food ingredients, with a commercial focus on protein and other products extracted from Australian lupins. The company is reviewing contract manufacturing options while assessing longer-term domestic processing capacity. Against that backdrop, its shares were indicated at AUD 0.01 in the price information available for this article. Recent disclosures describe a proposed Western Australian facility, further manufacturing discussions and a reduction in the company’s annual reported loss.

Company Business

Wide Open Agriculture (ASX:WOA) is pursuing commercial applications for its proprietary lupin ingredients, including Buntine Protein, across food and beverage categories. The business model encompasses ingredient development, intellectual property, customer relationships and manufacturing arrangements. Its strategy has changed as the company seeks to separate the cost of operating production facilities from the task of building market demand. Contract manufacturing could provide an alternative to owning and operating processing assets, although delivery depends on counterparties meeting technical, quality and commercial requirements.

Recent Development

On 6 October 2026, Wide Open Agriculture (ASX:WOA) released an industrial-scale study concerning a possible Western Australian lupin protein plant. The concept considered an annual processing capacity of approximately 10,000 tonnes of lupin protein product and an indicative capital requirement of roughly AUD 311mn. These estimates concern a proposed project, not a facility under construction; the company had not announced secured funding, a final investment decision or committed production from that project. The study provides a basis for further analysis rather than a near-term revenue forecast.

Separately, the company announced three additional framework agreements on 14 September 2026 with prospective contract manufacturers in Asia. The arrangements followed an earlier August framework agreement and are principally intended to support technical and commercial evaluation. The manufacturing frameworks are non-binding on core production commitments, so they should not be interpreted as completed supply contracts or evidence of contracted sales. The company must still establish whether prospective partners can consistently manufacture ingredients to required specifications and at viable costs.

Financial Performance and Sector Context

In its FY26 preliminary results, Wide Open Agriculture (ASX:WOA) reported a group loss after tax of AUD 3.64mn, narrowing from AUD 6.89mn in FY25. Operating revenue including discontinued operations was AUD 826,303, versus AUD 468,870 in the prior year. Cash and cash equivalents at 30 June 2026 were reported at approximately AUD 1.20mn on the consolidated balance sheet, compared with AUD 3.39mn a year earlier. The reported result also reflected discontinued operations following the restructuring of its German subsidiary.

The operating context remains shaped by demand for differentiated plant-based ingredients, production economics, product validation and customers’ willingness to adopt lupin-derived formulations. Wide Open Agriculture (ASX:WOA) has pursued ingredient testing and manufacturing partnerships to support commercialisation. However, higher indicative market opportunity or theoretical plant capacity does not by itself establish achievable sales volumes, cash flows or margins.

Risks to Consider

The key execution risk is whether manufacturing studies and framework agreements progress into operational capacity, binding commercial terms and repeat customer orders. The proposed Australian facility would require substantial financing and further approvals if taken forward. There is also potential for product development, logistics and quality-assurance costs to exceed assumptions. With a relatively small reported cash balance at FY26 year-end, future funding requirements and expenditure discipline remain relevant. The low nominal share price can also make percentage movements appear large when measured in fractions of a cent.

What to Watch Next

Attention will centre on Wide Open Agriculture (ASX:WOA) reporting progress with prospective manufacturers, confirming production economics, and providing evidence of customer demand for its lupin ingredients. Investors will also be able to assess the next quarterly cash-flow disclosure for changes in operating expenditure, available liquidity and funding sources. Any subsequent announcement about the proposed Western Australian plant should be examined for the distinction between engineering assumptions, financing arrangements and a formal development decision.

Key Insights

Wide Open Agriculture (ASX:WOA) is moving from an owner-operated manufacturing approach toward third-party production while maintaining a longer-term option for an Australian facility. FY26 results indicate a narrower reported loss, but the commercial transition remains incomplete. The immediate questions concern manufacturing feasibility, contracted demand and cash resources rather than the indicative output of an undeveloped plant.